The stock finally ended 5.5% higher at Rs 344.60. The stock clocked a volume of 95,060 shares on the BSE.
Pfitzer moved up marginally at Rs 730. Around 7,268 shares were traded at the BSE.
_________________________________________________
Updated at 1221 Hrs:
Aurobindo Pharma has rallied 6% on extending partnership with Pfizer.
The stock opened flat at Rs 329. It slipped to a low of Rs 325 but managed to rebound and touch a high of Rs 348, up 7%. The stock is currently trading up 6% at Rs 345. A total of 49,996 shares have been traded on the BSE so far.
Aurobindo Pharma has informed the BSE that it has extended it's partnership with Pfizer by executing licensing and supply agreements for a number of products.
Meanwhile, Pfizer is up 1% at Rs 730.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app